EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY 4.0

A centre-based ambulatory care concept for hidradenitis suppurativa improves disease activity, disease burden and patient satisfaction: results from the randomized controlled EsmAiL trial

Michael Schultheis iD, Petra Staubach, Georgios Nikolakis, Lukas Schollenberger, Melanie Mauch, Marion Burckhardt, Marcus Heise, Marina Zamsheva, Alexandra Strobel, Gero Langer, Falk Bechara, Uwe Kirschner und 4 weitere

British Journal of Dermatology · 17.07.2023 · 189 (2) · 170-179

DOI: 10.1093/bjd/ljad135 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift British Journal of Dermatology, online erschienen am 03.05.2023. Verfasst von Michael Schultheis und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gemeinsamer Bundesausschuss.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hidradenitis suppurativa (HS) is an inflammatory disease of the inverse skin regions that occurs in young women, in particular, and affects approximately 1% of the population. Outpatient care is often inadequate and usually cannot prevent progression.

Objectives

To evaluate in the EsmAiL (‘Evaluation eines strukturierten und leitlinienbasierten multmodalen Versorgungskonzepts für Menschen mit Akne inversa’) trial whether an innovative care concept can decrease disease activity and burden, and improve patient satisfaction.

Methods

EsmAiL was conducted as a two-arm, multicentre, prospective, randomized controlled trial that included 553 adults with HS. Inclusion criteria were a minimum of three inflammatory lesions and at least a moderate impact of the disease on quality of life. The control group (CG) remained under standard care, while patients in the intervention group (IG) were treated according to a trial-specific, multimodal concept. The primary endpoint was the absolute change in International Hidradenitis Suppurativa Severity Score System (IHS4).

Results

In total, 274 patients were randomized to the IG and 279 to the CG. Altogether, 377 attended the final assessment after 12 months of intervention. Participants in the IG (n = 203) achieved a mean improvement in IHS4 of 9.3 points, while the average decrease in IHS4 in patients in the CG (n = 174) was 5.7 points (P = 0.003). Patients treated under the new care concept also reported a statistically significantly higher decrease in pain, Dermatology Life Quality Index and Hospital Anxiety and Depression Scale scores compared with those in the CG (P < 0.001). Patient satisfaction was also statistically significantly higher in the IG compared with the CG (P < 0.001).

Conclusions

The establishment of standardized treatment algorithms in so-called ‘acne inversa centres’ in the ambulatory setting has a substantial, positive impact on the course of HS and significantly improves patient satisfaction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hidradenitis SuppurativaAdultHumansFemaleQuality of LifeProspective StudiesCost of IllnessAmbulatory CareSeverity of Illness Index

Autor:innen und Institutionen

  • Department of Dermatology and.
  • Department of Dermatology, Dessau Medical Center, Brandenburg Medical School Theodor Fontane, Dessau, Germany.
  • Interdisciplinary Centre for Clinical Trials, University Medical Center, Johannes Gutenberg University, Mainz, Germany.
  • German Society for Wound Healing and Wound Treatment (DGfW), Giessen, Germany.
  • Baden-Wuerttemberg Cooperative State University, School of Business and Health, Stuttgart, Germany.
  • Institute for Health and Nursing Science.

ORCID-Profile: Michael Schultheis, Stephan Grabbe

Förderung

  • Gemeinsamer Bundesausschuss

Zitieren

APA

Schultheis, M., Staubach, P., Nikolakis, G., Schollenberger, L., Mauch, M., Burckhardt, M., Heise, M., Zamsheva, M., Strobel, A., Langer, G., Bechara, F., Kirschner, U., Hennig, K., Kunte, C., Goebeler, M., & Grabbe, S. (2023). A centre-based ambulatory care concept for hidradenitis suppurativa improves disease activity, disease burden and patient satisfaction: results from the randomized controlled EsmAiL trial. British Journal of Dermatology, 189(2), 170-179. https://doi.org/10.1093/bjd/ljad135

Vancouver

Schultheis M, Staubach P, Nikolakis G, Schollenberger L, Mauch M, Burckhardt M, et al. A centre-based ambulatory care concept for hidradenitis suppurativa improves disease activity, disease burden and patient satisfaction: results from the randomized controlled EsmAiL trial. British Journal of Dermatology. 2023;189(2):170-179. doi:10.1093/bjd/ljad135

BibTeX
@article{Schultheis2023,
  author = {Schultheis, Michael and Staubach, Petra and Nikolakis, Georgios and Schollenberger, Lukas and Mauch, Melanie and Burckhardt, Marion and Heise, Marcus and Zamsheva, Marina and Strobel, Alexandra and Langer, Gero and Bechara, Falk and Kirschner, Uwe and Hennig, Katharina and Kunte, Christian and Goebeler, Matthias and Grabbe, Stephan},
  title = {A centre-based ambulatory care concept for hidradenitis suppurativa improves disease activity, disease burden and patient satisfaction: results from the randomized controlled EsmAiL trial},
  journal = {British Journal of Dermatology},
  year = {2023},
  volume = {189},
  number = {2},
  pages = {170--179},
  doi = {10.1093/bjd/ljad135}
}
Kostenlos starten →